Abhimanyu Garg, MD
Endocrinology, Diabetes & Metabolism · Dallas, TXNPI 1871562355
Payments from drug & device makers
Across 633 payments — averaging $1453.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$399K
- Chiesi USA, Inc.$229K
- Amryt Pharma Holdings Ltd$179K
- Akcea Therapeutics, Inc.$61K
- Aegerion Pharmaceuticals, Inc.$52K
- Abbott$137
Across 15 payments — averaging $224.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$3K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 395 | $399,011 |
| Chiesi USA, Inc. | 80 | $228,901 |
| Amryt Pharma Holdings Ltd | 127 | $179,261 |
| Akcea Therapeutics, Inc. | 2 | $61,109 |
| Aegerion Pharmaceuticals, Inc. | 28 | $51,696 |
| Abbott | 1 | $137 |
How this compares
$920,113 in reported general payments places this provider in the 90th percentile of 658 endocrinology, diabetes & metabolism providers in Texas.
See all endocrinology, diabetes & metabolism providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Dallas
- Julio RosenstockDallas$24.9M
- Ildiko LingvayDallas$8.2M
- Peter BresslerDallas$4.2M
- Steve FordanDallas$2.8M
- Pablo MoraDallas$2.1M
- Saleemah FahmiDallas$1.2M
- Priscilla HollanderDallas$1M
- Oksana HamidiDallas$1M
- Amy ShahDallas$953K
- Michelle WelchShavano Park$17.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.